Highlights:
-Are “off-the-shelf” fenestrated endografts seeing a new dawn?
-Lower restenosis and re-occlusion rates with drug-eluting balloons compared to angioplasty in DEBATE-BTK
-Dismantling the different myths around the CREST trial
-Profile: Patrick Peeters
[pdfviewer width=”100%” height=”940px” beta=”true”]https://vascularnews.com/wp-content/uploads/sites/7/2016/02/53-Vascular-News_low-res.pdf[/pdfviewer]
